Molecular imaging of atherosclerotic plaque with 64Cu-labeled natriuretic peptide and PET

Journal of Nuclear Medicine

Volumn 51, Issue 1, 2010, Pages 85-91

  Liu, Yongjian ^a   Abendschein, Dana ^a   Woodard, Geoffrey E ^b   Rossin, Raffaella ^a   McCommis, Kyle ^a   Zheng, Jie ^a   Welch, Michael J ^a   Woodard, Pamela K ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Atherosclerosis; Natriuretic peptide; PET; Vascular targeting

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; ATRIAL NATRIURETIC FACTOR; C TYPE ATRIAL NATRIURETIC FACTOR; COPPER 64; NATRIURETIC PEPTIDE RECEPTOR C; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; DISEASE COURSE; DRUG CLEARANCE; DRUG CONJUGATION; DRUG UPTAKE; HISTOPATHOLOGY; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; ISOTOPE LABELING; MOLECULAR IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RABBIT; SENSITIVITY AND SPECIFICITY;

ANIMALS; ATHEROSCLEROSIS; ATRIAL NATRIURETIC FACTOR; CHOLESTEROL; COPPER RADIOISOTOPES; IMMUNOHISTOCHEMISTRY; ISOTOPE LABELING; MAGNETIC RESONANCE IMAGING; NATRIURETIC PEPTIDE, C-TYPE; ORGANOMETALLIC COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY; RABBITS; RADIOPHARMACEUTICALS; RECEPTORS, ATRIAL NATRIURETIC FACTOR;

EID: 75149142267     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.109.066977     Document Type: Article

References (31)

1. World Health Organization. The Top 10 Causes of Death. Available at: http://www.who.int/mediacentre/factsheets/fs310/en/index.html. Accessed November 13, 2009.
2. Ibanez B, Badimon JJ, Garcia MJ. Diagnosis of atherosclerosis by imaging. Am J Med. 2009;122(1, suppl):S15-S25.
3. Langer HF, Haubner R, Pichler BJ, Gawaz M. Radionuclide imaging: a molecular key to the atherosclerotic plaque. J Am Coll Cardiol. 2008;52:1-12.
4. Davies JR, Rudd JH, Weissberg PL. Molecular and metabolic imaging of atherosclerosis. J Nucl Med. 2004;45:1898-1907.
5. Laurberg JM, Olsen AK, Hansen SB, et al. Imaging of vulnerable atherosclerotic plaques with FDG-microPET: no FDG accumulation. Atherosclerosis. 2007; 192:275-282.
6. Beer AJ, Schwaiger M. Imaging of integrin avb3 expression. Cancer Metastasis Rev. 2008;27:631-644.
7. Jaffer FA, Libby P, Weissleder R. Molecular and cellular imaging of atherosclerosis: emerging applications. J Am Coll Cardiol. 2006;47:1328-1338.
8. Daniels LB,Maisel AS. Natriuretic peptides. J Am Coll Cardiol. 2007;50:2357-2368.
9. Ahluwalia A, Hobbs AJ. Endothelium-derived C-type natriuretic peptide: more than just a hyperpolarizing factor. Trends Pharmacol Sci. 2005;26:162-167.
10. Maack T. The broad homeostatic role of natriuretic peptides. Arq Bras Endocrinol Metabol. 2006;50:198-207.
11. Maack T. Receptors of atrial natriuretic factor. Annu Rev Physiol. 1992;54:11-27.
12. Casco VH, Veinot JP, Kuroski de Bold ML, Masters RG, Stevenson MM, de Bold AJ. Natriuretic peptide system gene expression in human coronary arteries. J Histochem Cytochem. 2002;50:799-809.
13. Naruko T, Ueda M, van der Wal AC, et al. C-type natriuretic peptide in human coronary atherosclerotic lesions. Circulation. 1996;94:3103-3108.
14. Brown J, Chen Q, Hong G. An autocrine system for C-type natriuretic peptide within rat carotid neointima during arterial repair. Am J Physiol. 1997;272: H2919-H2931.
15. Leidenfrost JE, Khan MF, Boc KP, et al. A model of primary atherosclerosis and post-angioplasty restenosis in mice. Am J Pathol. 2003;163:773-778.
16. Maack T, Suzuki M, Almeida FA, et al. Physiological role of silent receptors of atrial natriuretic factor. Science. 1987;238:675-678.
17. Zheng J, Ochoa E, Misselwitz B, et al. Targeted contrast agent helps to monitor advanced plaque during progression: a magnetic resonance imaging study in rabbits. Invest Radiol. 2008;43:49-55.
18. 64Cu-labeled polymer nanoparticles targeted to the lung endothelium. J Nucl Med. 2008;49:103-111.
19. 64Cu using a biomedical cyclotron. Nucl Med Biol. 1997;24: 35-43.
20. Sarembock IJ, LaVeau PJ, Sigal SL, et al. Influence of inflation pressure and balloon size on the development of intimal hyperplasia after balloon angioplasty: a study in the atherosclerotic rabbit. Circulation. 1989;80:1029-1040.
21. Meding J, Urich M, Licha K, et al. Magnetic resonance imaging of atherosclerosis by targeting extracellular matrix deposition with gadofluorine M. Contrast Media Mol Imaging. 2007;2:120-129.
22. Sun X, Fang H, Li X, Rossin R, Welch MJ, Taylor JS. MicroPET imaging of MCF-7 tumors in mice via unr mRNA-targeted peptide nucleic acids. Bioconjug Chem. 2005;16:294-305.
23. Bell MR, Gersh BJ. Restenosis: a clinician's perspective. In: Schwartz RS, ed. Coronary Restenosis. Oxford, England: Blackwell Scientific Publications; 1993:15-54.
24. 123I-labeled synthetic peptide fragment. J Clin Pharmacol. 1993;33:1039-1047.
25. 99mTc-labeled low density lipoproteins. Arteriosclerosis. 1988;8:461-470.
26. 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations. J Nucl Med. 2008;49:871-878.
27. Rosen JM, Butler SP, Meinken GE, et al. Indium-111-labeled LDL: a potential agent for imaging atherosclerotic disease and lipoprotein biodistribution. J Nucl Med. 1990;31:343-350.
28. Worthley SG, Zhang ZY, Machac J, et al. In vivo non-invasive serial monitoring of FDG-PET progression and regression in a rabbit model of atherosclerosis. Int J Cardiovasc Imaging. 2009;25:251-257.
29. Kolodgie FD, Petrov A, Virmani R, et al. Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: a technique with potential for noninvasive imaging of vulnerable plaque. Circulation. 2003;108:3134-3139.
30. 99mTc-labeled anti-LOX-1 antibody: potential agent for imaging of vulnerable plaque. J Nucl Med. 2008;49:1677-1685.
31. Ohtsuki K, Hayase M, Akashi K, Kopiwoda S, Strauss HW. Detection of monocyte chemoattractant protein-1 receptor expression in experimental atherosclerotic lesions: an autoradiographic study. Circulation. 2001;104:203-208.